MTOR and cancer: OC had also been reported to inhibit mesenchymal-epithelial transition factor (c-MET) receptor tyrosine kinase and its downstream signaling pathways, reducing the activation of the mechanistic target of rapamycin (mTOR) levels, and suppressing COX-2 expression in different cancer types [27].